h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide has been researched along with aminocaproic acid in 1 studies
*Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. [MeSH]
*Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. [MeSH]
| Studies (h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide) | Trials (h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide) | Recent Studies (post-2010) (h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide) | Studies (aminocaproic acid) | Trials (aminocaproic acid) | Recent Studies (post-2010) (aminocaproic acid) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 1,793 | 132 | 302 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Machovich, R; Owen, WG | 1 |
1 other study(ies) available for h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide and aminocaproic acid
| Article | Year |
|---|---|
Facilitation of plasminogen activation by a plasmin substrate containing a lysyl residue.
Topics: Aminocaproic Acid; Animals; Binding Sites; Enzyme Activation; Fibrinolysin; Humans; Hydrolysis; Kringles; Lysine; Oligopeptides; Plasminogen; Substrate Specificity; Swine; Urokinase-Type Plasminogen Activator | 1993 |